Jan 10, 2022
Ovarian cancer has a poor prognosis because it is often diagnosed at a late stage, when a cure is difficult. For this reason, researchers at the Leibniz Research Centre for Working Environment and Human Factors in Dortmund (IfADo) are trying to understand the molecular mechanisms of the disease more precisely. An important feature of ovarian cancer, and cancer in general, is the reprograming of the metabolic capacity of cancer cells to facilitate their survival. In a recently funded DFG project entitled “Intracellularly derived lysophosphatidic acid (LPA) and glycerophospholipid metabolism in ovarian cancer”, key metabolic proteins and their contribution to cancer development are being analysed.
Continue reading →